U.S. Water Utilities Stock News

Datadog (NasdaqGS:DDOG) used its recent Investor Day to outline new steps in autonomous observability and AI centric capabilities across its platform. The company spotlighted agentic and AI native use cases, along with fresh disclosures on Security customer adoption and AI usage metrics. Management framed these updates as part of an ongoing shift toward AI driven observability and security services for cloud workloads. Datadog runs a cloud based observability and security platform that...

Palo Alto Networks (NasdaqGS:PANW) is acquiring Chronosphere, CyberArk, and Koi to expand its AI driven cybersecurity platform. The company is rolling out Unit 42 Managed XSIAM 2.0, an updated managed security operations center offering. New integrations, including with Aeris for IoT security, aim to address emerging risks such as AI driven cyberattacks. Palo Alto Networks sits at the center of enterprise security, with a platform that spans network, cloud, identity, and endpoint...

Tennant (TNC) is back on investors’ radar after recent share price moves, with the stock closing at US$82.30 and posting mixed returns over the past year and past 3 months. See our latest analysis for Tennant. Those moves come after a choppy year, with a 30 day share price return of 5.97% and a 90 day share price return of 11.73%. The 1 year total shareholder return sits at a 4.30% loss, which suggests momentum has picked up recently, while longer term holders have seen more modest...

YETI Holdings (NYSE:YETI) has appointed Scott Bomar as its new Chief Financial Officer. Bomar succeeds longtime CFO Mike McMullen, who will transition to an advisory role. The leadership change reflects an important shift in YETI’s finance function and executive team. YETI Holdings, trading at $45.21, has seen a 21.9% return over the past year, while its 5 year return stands at a 36.5% decline. In the shorter term, the stock shows a 5.8% decline over the past week and a 4.7% decline over...

In recent months, Toro has delivered a series of positive earnings surprises, and analysts have responded by revising their earnings estimates higher, contributing to growing investor confidence in the business. This pattern of consistently outperforming expectations has also supported a favorable analyst ranking for Toro, highlighting how earnings execution can materially influence sentiment around the company’s outlook. Now we’ll explore how Toro’s sustained earnings outperformance and...

Earlier in February 2026, NETSTREIT Corp. completed a US$208.62 million follow-on equity offering of 10,980,000 common shares at US$19.00 each, soon after reporting higher quarterly and full-year revenues and declaring a quarterly dividend of US$0.22 per share. The combination of fresh equity capital, a modest dividend increase, and a swing from loss to profit provides new context for how NETSTREIT might fund future property acquisitions and support its income-focused REIT profile. We will...

In recent days, Duolingo has faced mixed analyst commentary and leadership changes ahead of its February 26, 2026 earnings release, alongside routine insider stock sales by senior executives under pre-arranged trading and tax-withholding plans. What stands out is the tension between concerns about slowing growth and the CFO transition, and continued analyst optimism around Duolingo’s artificial intelligence-driven product development and expected year-over-year earnings and revenue...

Texas Instruments stock overview after recent move Texas Instruments (TXN) shares recently traded around $219.86, drawing attention to how the chipmaker’s current valuation compares with its reported revenue of $17.68b and net income of $4.97b. See our latest analysis for Texas Instruments. Recent moves tell a mixed story, with a 30 day share price return of 13.73% and a 90 day gain of 35.91% pointing to building momentum. At the same time, the 1 year total shareholder return of 12.98% and 5...

Why COMPASS Pathways is back on investor radar COMPASS Pathways (NasdaqGS:CMPS) has attracted fresh attention after reporting highly statistically significant, clinically meaningful Phase 3 results for its COMP360 psilocybin therapy in treatment resistant depression, along with plans to seek a rolling FDA review. See our latest analysis for COMPASS Pathways. The latest COMP360 data and follow on offering come after a sharp 50.96% 90 day share price return and a 112.16% 1 year total...

Why Stryker’s new T2 Alpha Humerus Nailing System matters for shareholders Stryker (SYK) has rolled out its T2 Alpha Humerus Nailing System, a product aimed at simplifying complex humeral fracture procedures while integrating with the company’s existing nailing platform. For investors, this launch ties directly into Stryker’s broader trauma and orthopaedics portfolio. It raises questions about how a more unified system could influence hospital adoption, pricing power and long term procedure...

Crown Castle (NYSE:CCI) plans to exit its small cell and fiber businesses to focus on its core U.S. tower portfolio. The company is pursuing sales of these assets and reorganizing operations around its tower segment. Crown Castle has terminated its contract with DISH over unpaid obligations and is seeking recovery of amounts it believes are due. Crown Castle runs a large network of wireless towers that support mobile carriers across the U.S., putting it at the center of ongoing 4G and 5G...

If you are wondering whether Indivior Pharmaceuticals' current share price still offers value after a strong run, this article will walk through what the numbers suggest about that question. The stock trades at US$32.93, with returns of 299.2% over 1 year and 265.9% over 5 years. At the same time, the year-to-date result of a 7.8% decline and a 4.8% decline over the last 7 days hint at shifting views on both upside potential and risk. Recent news around Indivior Pharmaceuticals has focused...

Earnings beat and guidance lift put TE Connectivity (TEL) in focus TE Connectivity (TEL) is back on investors’ radar after first quarter fiscal 2026 adjusted earnings of $2.72 per share rose 39.5% year over year, accompanied by higher revenue, stronger orders, and upbeat second quarter guidance. See our latest analysis for TE Connectivity. Despite a modest 1-day share price return decline of 1.47% to US$231.28 and a 7-day share price return of 2.08% lower, TE Connectivity’s 1-year total...

Why Buckle is on investors’ radar today Buckle (BKE) is drawing attention after recent trading left the share price at US$52.96. This is prompting investors to reassess how its current valuation lines up with its earnings, cash generation, and longer term return profile. See our latest analysis for Buckle. Recent trading has been a bit choppy, with a 1 day share price return of 1.82% decline and a 30 day share price return of 3.9% gain set against a 6.12% decline over 90 days. Longer term...

In the months to 11 February 2026, Illumina completed a share repurchase program, buying back 9,958,000 shares, or 6.31% of its stock, for US$1.02 billion, while also unveiling an 18‑month NovaSeq X innovation roadmap that targets up to Q70 quality scores, faster runs, and higher read outputs. This combination of capital returns and higher‑performance, more cost‑efficient sequencing could materially influence how investors assess Illumina’s productivity, competitiveness, and longer‑term...

Lincoln Educational Services (LINC) has put solid numbers on the board for FY 2025, with fourth quarter revenue of US$142.9 million and basic EPS of US$0.41, alongside trailing twelve month revenue of US$518.2 million and EPS of US$0.65. The company has seen quarterly revenue move from US$119.4 million and EPS of US$0.22 in Q4 2024 to US$142.9 million and US$0.41 respectively in Q4 2025, while trailing twelve month EPS moved from US$0.32 to US$0.65 over the same period. This sets the stage...

Armstrong World Industries (AWI) has drawn investor attention after a recent move in its share price, with the stock closing at $192.83 and showing mixed returns across different time frames. See our latest analysis for Armstrong World Industries. The recent 1 day share price decline of 3.06% and 7 day share price return of 3.72% come after a period where momentum has cooled slightly, despite a 1 year total shareholder return of 33.32% and strong multi year total returns. If this move in...

AST SpaceMobile (NasdaqGS:ASTS) secured its first contract with the U.S. Space Development Agency, marking the company’s entry into government defense work. The company reported a successful deployment and unfolding of its BlueBird-6 satellite, described as the largest commercial communications array in low Earth orbit. These updates highlight parallel progress in AST SpaceMobile’s defense and commercial efforts in space based cellular broadband. AST SpaceMobile is building a space based...

Worthington Enterprises, a US industrial manufacturer focused on steel processing and pressure cylinders, has recently been criticized for multi‑year declines in annual sales and earnings per share, alongside weakening returns on capital that have raised questions about how effectively management has allocated resources in the past. This deterioration in core financial metrics has sharpened scrutiny of management’s capital deployment choices and their ability to improve the company’s...

Liberty Media’s Formula One Group tracking stock has come back into focus after its latest earnings and the recently announced pending sale of the Visa Cash App RB team at a substantial valuation, alongside shifting expectations for race-fee and media growth. This combination highlights how rising franchise values for F1 teams and evolving media and sponsorship economics could reshape the commercial appeal of Formula One’s central rights. We’ll now examine how the high valuation for the...

Pfizer recently reported positive progression-free survival data from Cohort 3 of its Phase 3 BREAKWATER trial, where BRAFTOVI plus cetuximab and FOLFIRI outperformed FOLFIRI with or without bevacizumab in previously untreated BRAF V600E-mutant metastatic colorectal cancer. This result strengthens the case for expanding BRAFTOVI-based options in first-line colorectal cancer and adds further weight to Pfizer’s oncology pipeline story. Next, we’ll examine how this new evidence for BRAFTOVI’s...

BioMarin Pharmaceutical Inc. has reported its fourth quarter and full-year 2025 results, with Q4 revenue rising to US$874.57 million and full-year revenue to US$3.22 billion, while the quarter shifted to a net loss of US$46.57 million and full-year net income eased to US$348.9 million. The combination of higher sales but weaker quarterly profitability, alongside fresh debt financing to support the pending Amicus Therapeutics acquisition and new conditional approval for VOXZOGO in Canada,...

What Bank of New York Mellon Corporation (BK) offers investors right now Bank of New York Mellon Corporation (BK) is drawing attention as investors weigh its recent share performance against fundamentals such as reported revenue of US$20.1b and net income of US$5.3b. BNY’s mixed recent returns, including a 1 day decline of 2.2% and a past month decline of 1.8%, sit alongside a past 3 months total return of 5.9% and 1 year total return of 34.0%. See our latest analysis for Bank of New York...

Cboe Global Markets recently filed an omnibus mixed shelf registration covering common and preferred stock, debt, warrants and other securities, and earlier this month its board declared a first-quarter 2026 cash dividend of US$0.72 per share, payable on March 13 to shareholders of record on February 27. Coming on the heels of a strong 10-K highlighting options leadership and new product launches, the shelf filing gives Cboe added flexibility to fund future initiatives while continuing to...